UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Neoplasm of the ovary as a cause of hyperamylasemia

Anales de medicina interna (Madrid, Spain : 1984), 1989-04, Vol.6 (4), p.207

1989

Volltextzugriff (PDF)

Pulseless disease as presenting form of temporal arteritis

Anales de medicina interna (Madrid, Spain : 1984), 1991-05, Vol.8 (5), p.260

1991

Volltextzugriff (PDF)

Cancer therapeutics: Targeting the apoptotic pathway

Critical reviews in oncology/hematology, 2014-06, Vol.90 (3), p.200-219

2014

Volltextzugriff (PDF)

Oral drugs in the treatment of metastatic colorectal cancer

Therapeutic Advances in Medical Oncology, 2021, Vol.13, p.17588359211009001

2021

Volltextzugriff (PDF)

Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive model

Clinical & translational oncology, 2014-10, Vol.16 (10), p.927-930

2014

Volltextzugriff (PDF)

Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

Kidney international, 2012-09, Vol.82 (6), p.652-663

2012

Volltextzugriff (PDF)

Association of creatine kinase and skin toxicity in phase I trials of anticancer agents

British journal of cancer, 2012-11, Vol.107 (11), p.1797-1800

2012

Volltextzugriff (PDF)

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status

PloS one, 2017-10, Vol.12 (10), p.e0175484-e0175484

2017

Volltextzugriff (PDF)

Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial

JMIR research protocols, 2022-05, Vol.11 (5), p.e34292-e34292

2022

Volltextzugriff (PDF)

Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study

Clinical & translational oncology, 2021, Vol.23 (1), p.122-129

2021

Volltextzugriff (PDF)

Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.586-586

2022

Volltextzugriff (PDF)

Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.188-188

2022

Volltextzugriff (PDF)

Treatment of metastatic colorectal cancer (mCRC) according to age

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.49-49

2020

Volltextzugriff (PDF)

The rate of tumor growth during treatment accurately predicts the FDA gold standard of overall survival [OS] in a broad range of malignancies

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2545-2545

2018

Volltextzugriff (PDF)

1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)

Annals of oncology, 2020-09, Vol.31, p.S770-S771

2020

Volltextzugriff (PDF)

Retrospective analysis of clinical characteristics of mCRC patients receiving three or more lines of chemotherapy

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.682-682

2019

Volltextzugriff (PDF)

Metastases resection in colorectal cancer patients with mutation in oncogene BRAF or tumors located on the right side: Experience at the HGUGM

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4041-4041

2020

Volltextzugriff (PDF)

Incidence of venous thromboembolic disease (VTE) in a cohort of patients with colorectal cancer (CRC) according to KRAS, NRAS and BRAF status

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15136-e15136

2019

Volltextzugriff (PDF)

Prognostic and predictive factors in metastasic colorectal cancer

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.690-690

2018

Volltextzugriff (PDF)

First-in-human clinical trial with intratumoral BO-112 in solid malignancies: A novel immunotherapy based in double-stranded RNA (dsRNA)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3082-3082

2017

Volltextzugriff (PDF)

Prognostic value of molecular biomarkers in mCRC

Annals of oncology, 2017-06, Vol.28, p.iii94-iii94

2017

Volltextzugriff (PDF)

A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors

Clinical cancer research, 2014-12, Vol.20 (24), p.6284-6294

2014

Volltextzugriff (PDF)

Influence of surgical parameters on mortality after surgery for extracapsular hip fractures in the elderly

Revista española de cirugía ortopédica y traumatología (English ed.), 2020-09, Vol.64 (5), p.342-349

2020

Volltextzugriff (PDF)

Effect of cilastatin on cisplatin-induced nephrotoxicity and on antitumoral activity

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e13535-e13535

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoplasm of the ovary as a cause of hyperamylasemia

Pulseless disease as presenting form of temporal arteritis

Cancer therapeutics: Targeting the apoptotic pathway

Oral drugs in the treatment of metastatic colorectal cancer

Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana’s predictive model

Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

Association of creatine kinase and skin toxicity in phase I trials of anticancer agents

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status

Effect of the Nutraceutical Micodigest 2.0 on the Complication Rate of Colorectal Cancer Surgery With Curative Intent: Protocol for a Placebo-Controlled Double-blind Randomized Clinical Trial

Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study

Prognosis and correlation with Ca19.9 of circulating tumor cells (CTCs) in locally advanced and metastatic pancreatic cancer

Clinical evolution after surgery of hepatic metastases of colorectal cancer according to genomic profile

Analysis of survival trends, clinical, and molecular characteristics of patients with early-onset colorectal cancer (EOCRC)

Treatment of metastatic colorectal cancer (mCRC) according to age

The rate of tumor growth during treatment accurately predicts the FDA gold standard of overall survival [OS] in a broad range of malignancies

1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)

Retrospective analysis of clinical characteristics of mCRC patients receiving three or more lines of chemotherapy

Metastases resection in colorectal cancer patients with mutation in oncogene BRAF or tumors located on the right side: Experience at the HGUGM

Incidence of venous thromboembolic disease (VTE) in a cohort of patients with colorectal cancer (CRC) according to KRAS, NRAS and BRAF status

Prognostic and predictive factors in metastasic colorectal cancer

First-in-human clinical trial with intratumoral BO-112 in solid malignancies: A novel immunotherapy based in double-stranded RNA (dsRNA)

Prognostic value of molecular biomarkers in mCRC

A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors

Influence of surgical parameters on mortality after surgery for extracapsular hip fractures in the elderly

Effect of cilastatin on cisplatin-induced nephrotoxicity and on antitumoral activity

Suchergebnisse filtern